The findings were published in Nature Nanotechnology and reported by ANI, with the article dated May 20, 2026.

The study found that glycocalyx patterns change with cell state, with immune cell activation altering sugar layouts and cancerous tissues showing distinct surface signatures.

Nanoscale sugar arrangements can distinguish cellular states, including cancer development stages and differences between cancerous and healthy breast tissue.

Diagnostic potential is highlighted as Glycan Atlasing could enable early, objective disease detection and inform future diagnostic methods.

A team at the Max Planck Institute used Glycan Atlasing and super-resolution microscopy to map the glycocalyx at single-sugar resolution.

Glycan Atlasing proposes reading cell-surface sugar patterns as a foundation for future diagnostics, enabling early disease detection and objective assessment of disease progression or treatment response.

Glycan Atlasing leverages super-resolution microscopy to map glycocalyx structures across various cell types, including cell cultures, primary human blood cells, and tissue samples.

Published in Nature Nanotechnology, the work provides evidence that the glycocalyx acts as a display screen conveying information about a cell’s internal state.

Future plans include expanding the method to analyze more target structures, increasing automation, studying larger sample sets, and moving toward routine clinical use for detecting disease progression or therapeutic responses.

The researchers aim to correlate surface glycan patterns with disease progression and therapeutic responses to provide objective early detection through cell-surface signatures.

The work demonstrates that readable, structured biological information exists on the cell surface, with Glycan Atlasing yielding reliable readouts in complex samples.

Researchers developed Glycan Atlasing, a super-resolution imaging approach to map the glycocalyx—the sugar coating on human cells—at the level of individual sugar molecules.